Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

33.10p
   
  • Change Today:
    -0.60p
  • 52 Week High: 71.80
  • 52 Week Low: 32.90
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,864,058
  • Market Cap: £178.87m
  • RiskGrade: 119

Regulatory News

Result of AGM 25-May-2023 12:44 RNS
AGM Statement 25-May-2023 07:00 RNS
Total Voting Rights 03-May-2023 12:25 RNS
Notification of Major Holdings 03-May-2023 12:08 RNS
Annual Report and Notice of AGM 12-Apr-2023 10:00 RNS
Notification of Major Holdings 05-Apr-2023 11:00 RNS
Notification of Major Holdings 04-Apr-2023 10:46 RNS
Total Voting Rights 03-Apr-2023 10:04 RNS
Notification of Major Holdings 31-Mar-2023 15:00 RNS
Notification of Major Holdings 29-Mar-2023 07:00 RNS
Notification of Major Holdings 21-Mar-2023 16:59 RNS
Preliminary Results 21-Mar-2023 07:00 RNS
Notification of Major Holdings 14-Mar-2023 13:47 RNS
Notification of Major Holdings 07-Mar-2023 12:51 RNS
Notification of Full Year Results 23-Feb-2023 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 33.10p
Change Today -0.60p
% Change -1.78 %
52 Week High 71.80
52 Week Low 32.90
Volume 1,864,058
Shares Issued 540.40m
Market Cap £178.87m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.55% above the market average93.55% above the market average93.55% above the market average93.55% above the market average93.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
75.35% below the market average75.35% below the market average75.35% below the market average75.35% below the market average75.35% below the market average
12.73% below the sector average12.73% below the sector average12.73% below the sector average12.73% below the sector average12.73% below the sector average
Income
33.67% above the market average33.67% above the market average33.67% above the market average33.67% above the market average33.67% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
88.91% below the market average88.91% below the market average88.91% below the market average88.91% below the market average88.91% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 03-May-2024

Time Volume / Share Price
16:35 83,605 @ 33.10p
16:35 4,891 @ 33.10p
16:35 1,099 @ 33.10p
16:35 1,203 @ 33.10p
16:35 1,817 @ 33.10p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page